Literature DB >> 10320124

Disorders of neuromuscular junction ion channels.

K Boonyapisit1, H J Kaminski, R L Ruff.   

Abstract

Ion channel defects produce a clinically diverse set of disorders that range from cystic fibrosis and some forms of migraine to renal tubular defects and episodic ataxias. This review discusses diseases related to impaired function of the skeletal muscle acetylcholine receptor and calcium channels of the motor nerve terminal. Myasthenia gravis is an autoimmune disease caused by antibodies directed toward the skeletal muscle acetylcholine receptor that compromise neuromuscular transmission. Congenital myasthenias are genetic disorders, a subset of which are caused by mutations of the acetylcholine receptor. Lambert-Eaton myasthenic syndrome is an immune disorder characterized by impaired synaptic vesicle release likely related to a defect of calcium influx. The disorders will illustrate new insights into synaptic transmission and ion channel structure that are relevant for all ion channel disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10320124     DOI: 10.1016/s0002-9343(98)00374-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

Review 1.  Diagnosis and management of autoimmune myasthenia gravis.

Authors:  Corrado Angelini
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  Intercommunication between the neuroendocrine and immune systems: focus on myasthenia gravis.

Authors:  Jacqueline Mays; Cherié L Butts
Journal:  Neuroimmunomodulation       Date:  2011-09-22       Impact factor: 2.492

3.  Measurement of contractile force of skeletal and extraocular muscles: effects of blood supply, muscle size and in situ or in vitro preparation.

Authors:  Scott A Croes; Christopher S von Bartheld
Journal:  J Neurosci Methods       Date:  2007-07-04       Impact factor: 2.390

4.  Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection.

Authors:  Feng Lin; Henry J Kaminski; Bianca M Conti-Fine; Wei Wang; Chelliah Richmonds; M Edward Medof
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

5.  Clinical utility of videofluorography with concomitant Tensilon administration in the diagnosis of bulbar myasthenia gravis.

Authors:  Darren C Schwartz; Andrew J Waclawik; Sumit N Ringwala; Joanne Robbins
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

6.  The polyglutamine expansion in spinocerebellar ataxia type 6 causes a beta subunit-specific enhanced activation of P/Q-type calcium channels in Xenopus oocytes.

Authors:  S Restituito; R M Thompson; J Eliet; R S Raike; M Riedl; P Charnet; C M Gomez
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

7.  An undiagnosed myasthenia gravis presenting as isolated recurrent acute respiratory failure.

Authors:  Shri Ram Sharma; Nalini Sharma; Me Yeolekar
Journal:  J Neurosci Rural Pract       Date:  2012-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.